First Look Analysts Research Calls for Thursday, January 26
This report was sent to Briefing.com subscribers earlier today. Upgrades: > FibroGen (FGEN) upgraded to Outperform from Mkt Perform at Raymond James; tgt $35 Downgrades: > easyJet (ESYJY) downgraded to Mkt Perform from Outperform at Bernstein > EVgo Inc. (EVGO)…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> FibroGen (FGEN) upgraded to Outperform from Mkt Perform at Raymond James; tgt $35
Downgrades:
> easyJet (ESYJY) downgraded to Mkt Perform from Outperform at Bernstein
> EVgo Inc. (EVGO) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $6
> Hyatt Hotels (H) downgraded to Equal Weight from Overweight at Wells Fargo; tgt raised to $113
> Lending Club (LC) downgraded to Neutral from Buy at Janney; tgt $10
> Popular (BPOP) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $74
Others:
> Albemarle (ALB) initiated with an Overweight at Piper Sandler; tgt $310
> Datadog (DDOG) initiated with an Overweight at Cantor Fitzgerald; tgt $95
> Dexcom (DXCM) initiated with an Outperform at Wolfe Research; tgt $121
> Dyne Therapeutics (DYN) initiated with a Buy at Guggenheim; tgt $33
> Exelixis (EXEL) initiated with an Outperform at Credit Suisse; tgt $29
> JFrog (FROG) initiated with an Overweight at Cantor Fitzgerald; tgt $29
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.
